Updated: June 13, 2026

Venture Capital Firm
Aglaia Oncology Fund
USA
Aglaia is an oncology specialist investor which selects and matures early-stage breakthrough inventions that have the potential to transform cancer prevention diagnosis and therapy.
Built with Episolo ยท Free to start
Need an MVP before applying?
Turn your startup idea into a working web app using AI. No coding required.
Updated: June 13, 2026
Funding raised
$50M
About the program
Program type
Investment stage
Location
Countries invested
Numbers
FAQs about Aglaia Oncology Fund
What is Aglaia Oncology Fund?
Aglaia Oncology Fund is a Venture Capital Firm. Aglaia is an oncology specialist investor which selects and matures early-stage breakthrough inventions that have the potential to transform cancer prevention diagnosis and therapy.
Is Aglaia Oncology Fund an incubator, accelerator, or VC?
Aglaia Oncology Fund is listed as Venture Capital Firm. See the profile below for funding stages, offer, and application details.